
Guidelines for the Management of Hemophilia – Polish
The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Format: Video
On December 10th, 2020 Glenn Pierce, WFH VP Medical moderated this one-hour webinar in the Public Health Webinar Series on Blood Disorders presented by the CDC.
The webinar discussed how the WFH Guidelines for the Management of Hemophilia, 3rd edition provides opportunities to improve the standard of diagnosis and care for people with hemophilia around the world.
Steven Pipe, Maggie Ragni, and Manuel Carcao, eminent hematologists and section leads in the development of the guidelines, presented details of the recently published recommendations on
Their presentations were followed by an extensive and informative Q&A session.
To view a pdf of the slides from the webinar, click on the icon below.
Source: U.S. Centers for Disease Control & Prevention, December 2020.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

Presents data on the reported use of factor IX (FIX) per country. FIX use varies considerably, even among the wealthiest

An analysis of the global prevalence of hemophilia B, based in large part on the WFH’s Global Survey Data. Prevalence

This monograph highlights the prevalence and devastating impact of pain in hemophilia patients, reviews currently available treatment options, and identifies